TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs12197514
log Bayes Factor = 54.3906
Chromosome 6   position 27,553,784  (GRCh37) Explore rs12197514 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E83.1 Disorders of iron metabolism
1.000 0.000 0.000
K90.0 Coeliac disease
0.000 0.000 1.000
E05.9 Thyrotoxicosis, unspecified
0.000 0.075 0.925
K90 Intestinal malabsorption
0.000 0.243 0.757
K90.9 Intestinal malabsorption, unspecified
0.000 0.314 0.686
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.346 0.654
K90.3 Pancreatic steatorrhoea
0.000 0.457 0.543
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.457 0.543
K90.1 Tropical sprue
0.000 0.457 0.543
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.523 0.477
K90.8 Other intestinal malabsorption
0.000 0.579 0.421
E03.9 Hypothyroidism, unspecified
0.000 0.633 0.367
E03 Other hypothyroidism
0.000 0.648 0.352
E00-E07 Disorders of thyroid gland
0.000 0.652 0.348
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.656 0.344
E05.5 Thyroid crisis or storm
0.000 0.658 0.342
E05.4 Thyrotoxicosis factitia
0.000 0.658 0.342
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.658 0.342
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.658 0.342
E05.8 Other thyrotoxicosis
0.000 0.685 0.315
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.732 0.268
E03.5 Myxoedema coma
0.000 0.747 0.252
E03.4 Atrophy of thyroid (acquired)
0.000 0.747 0.252
E03.3 Postinfectious hypothyroidism
0.000 0.747 0.252
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.747 0.252
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.750 0.249
E00 Congenital iodine-deficiency syndrome
0.000 0.750 0.249
E03.1 Congenital hypothyroidism without goitre
0.000 0.762 0.238
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.774 0.226
E07 Other disorders of thyroid
0.000 0.786 0.214
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.806 0.194
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.821 0.179
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.821 0.179
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.821 0.179
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.821 0.179
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.821 0.179
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.821 0.179
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.821 0.179
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.821 0.179
E07.8 Other specified disorders of thyroid
0.000 0.822 0.178
E83 Disorders of mineral metabolism
0.166 0.834 0.000
E03.8 Other specified hypothyroidism
0.000 0.835 0.165
E07.1 Dyshormogenetic goitre
0.000 0.846 0.154
E07.0 Hypersecretion of calcitonin
0.000 0.846 0.154
E83.3 Disorders of phosphorus metabolism
0.135 0.865 0.000
E83.9 Disorder of mineral metabolism, unspecified
0.121 0.879 0.000
E83.8 Other disorders of mineral metabolism
0.119 0.881 0.000
E83.2 Disorders of zinc metabolism
0.119 0.881 0.000
E83.0 Disorders of copper metabolism
0.119 0.881 0.000
E06 Thyroiditis
0.002 0.885 0.113
E83.4 Disorders of magnesium metabolism
0.083 0.917 0.000
E06.4 Drug-induced thyroiditis
0.001 0.918 0.081
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.001 0.918 0.081
E06.0 Acute thyroiditis
0.001 0.918 0.081
E06.9 Thyroiditis, unspecified
0.001 0.920 0.078
E06.1 Subacute thyroiditis
0.001 0.922 0.076
E06.5 Other chronic thyroiditis
0.002 0.929 0.069
E07.9 Disorder of thyroid, unspecified
0.000 0.943 0.057
K90-K93 Other diseases of the digestive system
0.000 0.945 0.055
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.000 0.958 0.042
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.961 0.039
C79.7 Secondary malignant neoplasm of adrenal gland
0.000 0.961 0.039
C79 Secondary malignant neoplasm of other sites
0.000 0.963 0.037
C79.2 Secondary malignant neoplasm of skin
0.000 0.966 0.034
C79.9 Secondary malignant neoplasm, unspecified site
0.000 0.969 0.031
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.000 0.971 0.029
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.971 0.028
K93.1 Megacolon in Chagas' disease
0.000 0.971 0.028
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.971 0.028
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.000 0.975 0.025
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.000 0.977 0.023
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.000 0.979 0.021
E04 Other non-toxic goitre
0.001 0.980 0.020
C79.6 Secondary malignant neoplasm of ovary
0.000 0.981 0.019
E06.3 Autoimmune thyroiditis
0.003 0.982 0.014
R27.0 Ataxia, unspecified
0.017 0.983 0.000
K63.1 Perforation of intestine (nontraumatic)
0.000 0.984 0.016
E04.8 Other specified non-toxic goitre
0.001 0.985 0.014
D68.2 Hereditary deficiency of other clotting factors
0.014 0.986 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.000 0.987 0.013
C71.1 Frontal lobe
0.000 0.988 0.012
K91 Postprocedural disorders of digestive system, not elsewhere classified
0.000 0.988 0.012
R27 Other lack of coordination
0.011 0.989 0.000
E85.9 Amyloidosis, unspecified
0.011 0.989 0.000
E85 Amyloidosis
0.011 0.989 0.000
E70-E90 Metabolic disorders
0.011 0.989 0.000
R27.8 Other and unspecified lack of coordination
0.011 0.989 0.000
I42.9 Cardiomyopathy, unspecified
0.010 0.990 0.000
C71 Malignant neoplasm of brain
0.000 0.990 0.010
E88 Other metabolic disorders
0.010 0.990 0.000
C71.0 Cerebrum, except lobes and ventricles
0.000 0.990 0.010
E04.0 Non-toxic diffuse goitre
0.001 0.990 0.009
D68 Other coagulation defects
0.010 0.990 0.000
C71.2 Temporal lobe
0.000 0.991 0.009
G24.3 Spasmodic torticollis
0.009 0.991 0.000
D68.0 Von Willebrand's disease
0.009 0.991 0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.009 0.991 0.000
K91.1 Postgastric surgery syndromes
0.000 0.991 0.009
E85.8 Other amyloidosis
0.009 0.991 0.000
D68.5 Primary Thrombophilia
0.009 0.991 0.000
E88.3 Tumour lysis syndrome
0.009 0.991 0.000
E85.3 Secondary systemic amyloidosis
0.009 0.991 0.000
K91.9 Postprocedural disorder of digestive system, unspecified
0.000 0.991 0.008
E72 Other disorders of amino-acid metabolism
0.008 0.991 0.000
D68.6 Other Thrombophilia
0.008 0.991 0.000
E04.9 Non-toxic goitre, unspecified
0.000 0.992 0.008
E88.8 Other specified metabolic disorders
0.008 0.992 0.000
E85.2 Heredofamilial amyloidosis, unspecified
0.008 0.992 0.000
E85.1 Neuropathic heredofamilial amyloidosis
0.008 0.992 0.000
E85.0 Nonneuropathic heredofamilial amyloidosis
0.008 0.992 0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.008 0.992 0.000
E77 Disorders of glycoprotein metabolism
0.008 0.992 0.000
E76 Disorders of glycosaminoglycan metabolism
0.008 0.992 0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.008 0.992 0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.008 0.992 0.000
G24 Dystonia
0.008 0.992 0.000
K91.0 Vomiting following gastro-intestinal surgery
0.000 0.992 0.008
K91.2 Postsurgical malabsorption, not elsewhere classified
0.000 0.992 0.008
E80 Disorders of porphyrin and bilirubin metabolism
0.008 0.992 0.000
C71.7 Brain stem
0.000 0.992 0.008
C71.6 Cerebellum
0.000 0.992 0.008
C71.5 Cerebral ventricle
0.000 0.992 0.008
E88.2 Lipomatosis, not elsewhere classified
0.008 0.992 0.000
E84 Cystic fibrosis
0.008 0.992 0.000
T42.4 Benzodiazepines
0.008 0.992 0.000
C71.9 Brain, unspecified
0.000 0.992 0.008
E88.9 Metabolic disorder, unspecified
0.007 0.992 0.000
E85.4 Organ-limited amyloidosis
0.007 0.992 0.000
C71.8 Overlapping lesion of brain
0.000 0.993 0.007
E79 Disorders of purine and pyrimidine metabolism
0.007 0.993 0.000
E88.1 Lipodystrophy, not elsewhere classified
0.007 0.993 0.000
K91.3 Postoperative intestinal obstruction
0.000 0.993 0.007
E70 Disorders of aromatic amino-acid metabolism
0.007 0.993 0.000
C71.3 Parietal lobe
0.000 0.993 0.007
R69 Unknown and unspecified causes of morbidity
0.007 0.993 0.000
C71.4 Occipital lobe
0.000 0.993 0.007
G24.9 Dystonia, unspecified
0.007 0.993 0.000
D68.4 Acquired coagulation factor deficiency
0.007 0.993 0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.007 0.993 0.000
G24.8 Other dystonia
0.007 0.993 0.000
E80.1 Porphyria cutanea tarda
0.007 0.993 0.000
G30.9 Alzheimer's disease, unspecified
0.007 0.993 0.000
D68.1 Hereditary factor XI deficiency
0.007 0.993 0.000
G30 Alzheimer's disease
0.007 0.993 0.000
K40.9 Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.006 0.994 0.000
E72.9 Disorder of amino-acid metabolism, unspecified
0.006 0.994 0.000
E72.8 Other specified disorders of amino-acid metabolism
0.006 0.994 0.000
E72.5 Disorders of glycine metabolism
0.006 0.994 0.000
E72.4 Disorders of ornithine metabolism
0.006 0.994 0.000
E72.3 Disorders of lysine and hydroxylysine metabolism
0.006 0.994 0.000
E72.2 Disorders of urea cycle metabolism
0.006 0.994 0.000
E72.0 Disorders of amino-acid transport
0.006 0.994 0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified
0.000 0.994 0.006
E75.2 Other sphingolipidosis
0.006 0.994 0.000
K22.5 Diverticulum of oesophagus, acquired
0.000 0.994 0.006
E74 Other disorders of carbohydrate metabolism
0.006 0.994 0.000
E73 Lactose intolerance
0.006 0.994 0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.006 0.994 0.000
K91.4 Colostomy and enterostomy malfunction
0.000 0.994 0.006
K91.5 Postcholecystectomy syndrome
0.000 0.994 0.006
G30.0 Alzheimer's disease with early onset
0.006 0.994 0.000
E75.6 Lipid storage disorder, unspecified
0.006 0.994 0.000
E75.4 Neuronal ceroid lipofuscinosis
0.006 0.994 0.000
E75.3 Sphingolipidosis, unspecified
0.006 0.994 0.000
E75.1 Other gangliosidosis
0.006 0.994 0.000
E75.0 GM2 gangliosidosis
0.006 0.994 0.000
E71.3 Disorders of fatty-acid metabolism
0.006 0.994 0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.006 0.994 0.000
E71.1 Other disorders of branched-chain amino-acid metabolism
0.006 0.994 0.000
E71.0 Maple-syrup-urine disease
0.006 0.994 0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.006 0.994 0.000
E76.8 Other disorders of glucosaminoglycan metabolism
0.006 0.994 0.000
E76.3 Mucopolysaccharidosis, unspecified
0.006 0.994 0.000
E76.2 Other mucopolysaccharidoses
0.006 0.994 0.000
E76.1 Mucopolysaccharidosis, type II
0.006 0.994 0.000
E76.0 Mucopolysaccharidosis, type I
0.006 0.994 0.000
E77.9 Disorder of glycoprotein metabolism, unspecified
0.006 0.994 0.000
E77.8 Other disorders of glycoprotein metabolism
0.006 0.994 0.000
E77.1 Defects in glycoprotein degradation
0.006 0.994 0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.006 0.994 0.000
G24.4 Idiopathic orofacial dystonia
0.006 0.994 0.000
G24.2 Idiopathic nonfamilial dystonia
0.006 0.994 0.000
G24.1 Idiopathic familial dystonia
0.006 0.994 0.000
G24.0 Drug-induced dystonia
0.006 0.994 0.000
U81.0 Vancomycin resistant agent
0.006 0.994 0.000
E80.7 Disorder of bilirubin metabolism, unspecified
0.006 0.994 0.000
E80.5 Crigler-Najjar syndrome
0.006 0.994 0.000
E80.3 Defects of catalase and peroxydase
0.006 0.994 0.000
E80.0 Hereditary erythropoietic porphyria
0.006 0.994 0.000
E84.8 Cystic fibrosis with other manifestations
0.006 0.994 0.000
E84.1 Cystic fibrosis with intestinal manifestations
0.006 0.994 0.000
E84.0 Cystic fibrosis with pulmonary manifestations
0.006 0.994 0.000
G30.8 Other Alzheimer's disease
0.006 0.994 0.000
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament
0.006 0.994 0.000
E80.6 Other disorders of bilirubin metabolism
0.006 0.994 0.000
G31.8 Other specified degenerative diseases of nervous system
0.006 0.994 0.000
E75.5 Other lipid storage disorders
0.006 0.994 0.000
J06.9 Acute upper respiratory infection, unspecified
0.006 0.994 0.000
G31.9 Degenerative disease of nervous system, unspecified
0.006 0.994 0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.000 0.994 0.006
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.005 0.994 0.000
E79.8 Other disorders of purine and pyrimidine metabolism
0.005 0.994 0.000
E79.1 Lesch-Nyhan syndrome
0.005 0.994 0.000
E84.9 Cystic fibrosis, unspecified
0.005 0.994 0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.005 0.994 0.000
E70.8 Other disorders of aromatic amino-acid metabolism
0.005 0.994 0.000
E70.2 Disorders of tyrosine metabolism
0.005 0.994 0.000
E70.1 Other hyperphenylalaninaemias
0.005 0.994 0.000
E70.0 Classical phenylketonuria
0.005 0.994 0.000
E83.5 Disorders of calcium metabolism
0.005 0.994 0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified
0.006 0.994 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.006 0.994 0.000
T42.0 Hydantoin derivatives
0.005 0.994 0.000
G24.5 Blepharospasm
0.005 0.995 0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants
0.005 0.995 0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.005 0.995 0.000
E80.4 Gilbert's syndrome
0.005 0.995 0.000
T40.2 Other opioids
0.005 0.995 0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.005 0.995 0.000
E70.3 Albinism
0.005 0.995 0.000
C69 Malignant neoplasm of eye and adnexa
0.000 0.995 0.005
D68.8 Other specified coagulation defects
0.005 0.995 0.000
G30-G32 Other degenerative diseases of the nervous system
0.005 0.995 0.000
U81.8 Agent resistant to other vancomycin-related antibiotic
0.005 0.995 0.000
K07.3 Anomalies of tooth position
0.000 0.995 0.005
U81 Agent resistant to vancomycin and related antibiotics
0.005 0.995 0.000
E80.2 Other porphyria
0.005 0.995 0.000
E89.4 Postprocedural ovarian failure
0.005 0.995 0.000
G30.1 Alzheimer's disease with late onset
0.005 0.995 0.000
E74.9 Disorder of carbohydrate metabolism, unspecified
0.004 0.995 0.000
E74.8 Other specified disorders of carbohydrate metabolism
0.004 0.995 0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.004 0.995 0.000
E74.2 Disorders of galactose metabolism
0.004 0.995 0.000
E74.1 Disorders of fructose metabolism
0.004 0.995 0.000
E74.0 Glycogen storage disease
0.004 0.995 0.000
E73.8 Other lactose intolerance
0.004 0.995 0.000
E73.1 Secondary lactase deficiency
0.004 0.995 0.000
E73.0 Congenital lactase deficiency
0.004 0.995 0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.005 0.995 0.000
E89.8 Other postprocedural endocrine and metabolic disorders
0.005 0.995 0.000
E89.5 Postprocedural testicular hypofunction
0.005 0.995 0.000
E89.1 Postprocedural hypoinsulinaemia
0.005 0.995 0.000
I46.9 Cardiac arrest, unspecified
0.000 0.995 0.005
C70 Malignant neoplasm of meninges
0.000 0.995 0.004
C69.9 Eye, unspecified
0.000 0.995 0.004
K63.3 Ulcer of intestine
0.000 0.995 0.005
C69.3 Choroid
0.000 0.996 0.004
G25.8 Other specified extrapyramidal and movement disorders
0.004 0.996 0.000
D68.9 Coagulation defect, unspecified
0.004 0.996 0.000
E89.0 Postprocedural hypothyroidism
0.004 0.996 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.004 0.996 0.000
G31.1 Senile degeneration of brain, not elsewhere classified
0.004 0.996 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.004 0.996 0.000
T42.3 Barbiturates
0.004 0.996 0.000
T42.2 Succinimides and oxazolidinediones
0.004 0.996 0.000
J38.7 Other diseases of larynx
0.004 0.996 0.000
C69.6 Orbit
0.000 0.996 0.004
K63 Other diseases of intestine
0.000 0.996 0.004
T36-T50 Poisoning by drugs, medicaments and biological substances
0.004 0.996 0.000
K07.9 Dentofacial anomaly, unspecified
0.000 0.996 0.004
G25 Other extrapyramidal and movement disorders
0.004 0.996 0.000
C69.8 Overlapping lesion of eye and adnexa
0.000 0.996 0.004
C69.5 Lachrymal gland and duct
0.000 0.996 0.004
C69.4 Ciliary body
0.000 0.996 0.004
C69.1 Cornea
0.000 0.996 0.004
K63.9 Disease of intestine, unspecified
0.000 0.996 0.004
G20-G26 Extrapyramidal and movement disorders
0.004 0.996 0.000
C80.9 Malignant neoplasm, unspecified
0.004 0.996 0.000
C69.0 Conjunctiva
0.000 0.996 0.004
T43.5 Other and unspecified antipsychotics and neuroleptics
0.004 0.996 0.000
C70.0 Cerebral meninges
0.000 0.996 0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.004 0.996 0.000
K07 Dentofacial anomalies [including malocclusion]
0.000 0.996 0.004
K07.4 Malocclusion, unspecified
0.000 0.996 0.004
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.004 0.996 0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
0.000 0.996 0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.004 0.996 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.004 0.996 0.000
G32 Other degenerative disorders of nervous system in diseases classified elsewhere
0.004 0.996 0.000
G31.2 Degeneration of nervous system due to alcohol
0.004 0.996 0.000
E89.2 Postprocedural hypoparathyroidism
0.004 0.996 0.000
T40.1 Heroin
0.004 0.996 0.000
T50.8 Diagnostic agents
0.004 0.996 0.000
C69.2 Retina
0.000 0.996 0.003
K63.0 Abscess of intestine
0.000 0.996 0.004
J38.3 Other diseases of vocal cords
0.004 0.996 0.000
C70.9 Meninges, unspecified
0.000 0.996 0.003
C70.1 Spinal meninges
0.000 0.996 0.003
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.004 0.996 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.003 0.996 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.004 0.996 0.000
G25.9 Extrapyramidal and movement disorder, unspecified
0.003 0.996 0.000
G25.1 Drug-induced tremor
0.003 0.996 0.000
K92.8 Other specified diseases of digestive system
0.000 0.996 0.004
T42.1 Iminostilbenes
0.003 0.996 0.000
T40.5 Cocaine
0.003 0.996 0.000
T40.6 Other and unspecified narcotics
0.003 0.997 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.003 0.997 0.000
Q89.2 Congenital malformations of other endocrine glands
0.003 0.997 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.003 0.997 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.003 0.997 0.000
T40.8 Lysergide [LSD]
0.003 0.997 0.000
T40.7 Cannabis (derivatives)
0.003 0.997 0.000
T40.3 Methadone
0.003 0.997 0.000
T40.0 Opium
0.003 0.997 0.000
K92 Other diseases of digestive system
0.000 0.997 0.003
G21 Secondary Parkinsonism
0.003 0.997 0.000
E04.1 Non-toxic single thyroid nodule
0.001 0.997 0.002
G31.0 Circumscribed brain atrophy
0.003 0.997 0.000
E74.3 Other disorders of intestinal carbohydrate absorption
0.003 0.997 0.001
E89.3 Postprocedural hypopituitarism
0.003 0.997 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.003 0.997 0.000
G25.6 Drug-induced tics and other tics of organic origin
0.003 0.997 0.000
G25.4 Drug-induced chorea
0.003 0.997 0.000
Q25.1 Coarctation of aorta
0.003 0.997 0.000
E73.9 Lactose intolerance, unspecified
0.003 0.997 0.000
K07.2 Anomalies of dental arch relationship
0.000 0.997 0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.003 0.997 0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere
0.003 0.997 0.000
G22 Parkinsonism in diseases classified elsewhere
0.003 0.997 0.000
T50.4 Drugs affecting uric acid metabolism
0.003 0.997 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.003 0.997 0.000
G25.5 Other chorea
0.003 0.997 0.000
G25.3 Myoclonus
0.003 0.997 0.000
K07.6 Temporomandibular joint disorders
0.000 0.997 0.003
G25.2 Other specified forms of tremor
0.003 0.997 0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified
0.000 0.997 0.003
K07.5 Dentofacial functional abnormalities
0.000 0.997 0.003
G23 Other degenerative diseases of basal ganglia
0.003 0.997 0.000
C72.9 Central nervous system, unspecified
0.000 0.997 0.003
C72.8 Overlapping lesion of brain and other parts of central nervous system
0.000 0.997 0.003
C72.5 Other and unspecified cranial nerves
0.000 0.997 0.003
C72.4 Acoustic nerve
0.000 0.997 0.003
C72.3 Optic nerve
0.000 0.997 0.003
C72.2 Olfactory nerve
0.000 0.997 0.003
C72.1 Cauda equina
0.000 0.997 0.003
J35.0 Chronic tonsillitis
0.003 0.997 0.000
J38.4 Oedema of larynx
0.003 0.997 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.003 0.997 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.003 0.997 0.000
T37.5 Antiviral drugs
0.003 0.997 0.000
T37.4 Anthelminthics
0.003 0.997 0.000
T37.3 Other antiprotozoal drugs
0.003 0.997 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.003 0.997 0.000
T37.1 Antimycobacterial drugs
0.003 0.997 0.000
T37.0 Sulphonamides
0.003 0.997 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.003 0.997 0.000
T50.7 Analeptics and opioid receptor antagonists
0.003 0.997 0.000
T50.5 Appetite depressants
0.003 0.997 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.003 0.997 0.000
T50.1 Loop [high-ceiling] diuretics
0.003 0.997 0.000
T50.0 Mineralocorticoids and their antagonists
0.003 0.997 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.003 0.997 0.000
G21.1 Other drug-induced secondary Parkinsonism
0.003 0.997 0.000
G32.0 Subacute combined degeneration of spinal cord in diseases classified elsewhere
0.003 0.997 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.003 0.997 0.000
T92.1 Sequelae of fracture of arm
0.000 0.997 0.003
Q25.6 Stenosis of pulmonary artery
0.003 0.997 0.000
J45.0 Predominantly allergic asthma
0.003 0.997 0.000
T43.9 Psychotropic drug, unspecified
0.003 0.997 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.003 0.997 0.000
Q25 Congenital malformations of great arteries
0.003 0.997 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.003 0.997 0.000
T36 Poisoning by systemic antibiotics
0.003 0.997 0.000
J38 Diseases of vocal cords and larynx, not elsewhere classified
0.003 0.997 0.000
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand
0.000 0.997 0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.003 0.997 0.000
Q89 Other congenital malformations, not elsewhere classified
0.003 0.997 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.003 0.997 0.000
K07.0 Major anomalies of jaw size
0.000 0.997 0.003
G32.8 Other specified degenerative disorders of nervous system in diseases classified elsewhere
0.002 0.997 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.003 0.997 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.003 0.997 0.000
T47.7 Emetics
0.003 0.997 0.000
T47.6 Antidiarrhoeal drugs
0.003 0.997 0.000
T47.5 Digestants
0.003 0.997 0.000
T47.4 Other laxatives
0.003 0.997 0.000
T47.3 Saline and osmotic laxatives
0.003 0.997 0.000
T47.2 Stimulant laxatives
0.003 0.997 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.997 0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.003 0.997 0.000
T48.5 Anti-common-cold drugs
0.003 0.997 0.000
T48.4 Expectorants
0.003 0.997 0.000
T48.3 Antitussives
0.003 0.997 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.003 0.997 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.003 0.997 0.000
T48.0 Oxytocic drugs
0.003 0.997 0.000
C80 Malignant neoplasm without specification of site
0.002 0.997 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.003 0.997 0.000
G21.9 Secondary Parkinsonism, unspecified
0.002 0.997 0.000
G21.8 Other secondary Parkinsonism
0.002 0.997 0.000
G21.4 Vascular parkinsonism
0.002 0.997 0.000
G21.3 Postencephalitic Parkinsonism
0.002 0.997 0.000
G21.2 Secondary Parkinsonism due to other external agents
0.002 0.997 0.000
G21.0 Malignant neuroleptic syndrome
0.002 0.997 0.000
T43.6 Psychostimulants with abuse potential
0.003 0.997 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.003 0.997 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.003 0.997 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.003 0.997 0.000
K07.1 Anomalies of jaw-cranial base relationship
0.000 0.997 0.003
K07.8 Other dentofacial anomalies
0.000 0.997 0.002
T47.0 Histamine H(2)-receptor antagonists
0.002 0.997 0.000
J06 Acute upper respiratory infections of multiple and unspecified sites
0.003 0.997 0.000
L73.2 Hidradenitis suppurativa
0.003 0.997 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.002 0.997 0.000
K63.4 Enteroptosis
0.000 0.997 0.002
T92.2 Sequelae of fracture at wrist and hand level
0.000 0.997 0.003
T41.5 Therapeutic gases
0.002 0.997 0.000
T41.4 Anaesthetic, unspecified
0.002 0.997 0.000
T41.3 Local anaesthetics
0.002 0.997 0.000
T41.2 Other and unspecified general anaesthetics
0.002 0.997 0.000
T41.1 Intravenous anaesthetics
0.002 0.997 0.000
T41.0 Inhaled anaesthetics
0.002 0.997 0.000
T49.9 Topical agent, unspecified
0.002 0.997 0.000
T49.8 Other topical agents
0.002 0.997 0.000
T49.7 Dental drugs, topically applied
0.002 0.997 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.002 0.997 0.000
T49.5 Ophthalmological drugs and preparations
0.002 0.997 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.002 0.997 0.000
T49.3 Emollients, demulcents and protectants
0.002 0.997 0.000
T49.2 Local astringents and local detergents
0.002 0.997 0.000
T49.1 Antipruritics
0.002 0.997 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.002 0.997 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.997 0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.002 0.997 0.000
T92 Sequelae of injuries of upper limb
0.000 0.997 0.003
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)
0.002 0.998 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.002 0.998 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.002 0.998 0.000
C80.0 Malignant neoplasm, primary site unknown, so stated
0.002 0.998 0.000
G23.1 Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
0.002 0.998 0.000
G23.9 Degenerative disease of basal ganglia, unspecified
0.002 0.998 0.000
G23.3 Multiple system atrophy, cerebellar type
0.002 0.998 0.000
G23.2 Striatonigral degeneration
0.002 0.998 0.000
G23.0 Hallervorden-Spatz disease
0.002 0.998 0.000
Q25.4 Other congenital malformations of aorta
0.002 0.998 0.000
C72.0 Spinal cord
0.001 0.998 0.002
T43.2 Other and unspecified antidepressants
0.002 0.998 0.000
K14.0 Glossitis
0.002 0.998 0.000
T45.2 Vitamins, not elsewhere classified
0.002 0.998 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.002 0.998 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.002 0.998 0.000
T46.7 Peripheral vasodilators
0.002 0.998 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.002 0.998 0.000
Q89.3 Situs inversus
0.002 0.998 0.000
E16 Other disorders of pancreatic internal secretion
0.000 0.998 0.002
T93.9 Sequelae of unspecified injury of lower limb
0.002 0.998 0.000
T36.3 Macrolides
0.002 0.998 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.002 0.998 0.000
J38.5 Laryngeal spasm
0.002 0.998 0.000
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb
0.000 0.998 0.002
T36.9 Systemic antibiotic, unspecified
0.002 0.998 0.000
T36.8 Other systemic antibiotics
0.002 0.998 0.000
T36.7 Antifungal antibiotics, systemically used
0.002 0.998 0.000
T36.6 Rifamycins
0.002 0.998 0.000
T36.5 Aminoglycosides
0.002 0.998 0.000
T36.4 Tetracyclines
0.002 0.998 0.000
T36.2 Chloramphenicol group
0.002 0.998 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.002 0.998 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.002 0.998 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.002 0.998 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.002 0.998 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.002 0.998 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.002 0.998 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.002 0.998 0.000
T44.0 Anticholinesterase agents
0.002 0.998 0.000
Q25.9 Congenital malformation of great arteries, unspecified
0.002 0.998 0.000
Q25.8 Other congenital malformations of great arteries
0.002 0.998 0.000
Q25.7 Other congenital malformations of pulmonary artery
0.002 0.998 0.000
Q25.5 Atresia of pulmonary artery
0.002 0.998 0.000
Q25.2 Atresia of aorta
0.002 0.998 0.000
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)
0.002 0.998 0.000
S62.50 Fracture of thumb (closed)
0.000 0.998 0.002
Q25.0 Patent ductus arteriosus
0.002 0.998 0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use
0.002 0.998 0.000
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)
0.002 0.998 0.000
E16.1 Other hypoglycaemia
0.000 0.998 0.002
G23.8 Other specified degenerative diseases of basal ganglia
0.002 0.998 0.000
Q89.9 Congenital malformation, unspecified
0.002 0.998 0.000
Q89.8 Other specified congenital malformations
0.002 0.998 0.000
Q89.7 Multiple congenital malformations, not elsewhere classified
0.002 0.998 0.000
Q89.4 Conjoined twins
0.002 0.998 0.000
Q89.1 Congenital malformations of adrenal gland
0.002 0.998 0.000
Q89.0 Congenital malformations of spleen
0.002 0.998 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.002 0.998 0.000
T92.9 Sequelae of unspecified injury of upper limb
0.000 0.998 0.002
D21.2 Connective and other soft tissue of lower limb, including hip
0.002 0.998 0.000
N84.1 Polyp of cervix uteri
0.002 0.998 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.002 0.998 0.000
U51.0 Not Previously admitted to a psyciatric hospital
0.002 0.998 0.000
M05.9 Seropositive rheumatoid arthritis, unspecified
0.002 0.998 0.000
Q25.3 Stenosis of aorta
0.002 0.998 0.000
T92.4 Sequelae of injury of nerve of upper limb
0.000 0.998 0.002
Q80-Q89 Other congenital malformations
0.002 0.998 0.000
J38.6 Stenosis of larynx
0.002 0.998 0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems
0.002 0.998 0.000
L72.0 Epidermal cyst
0.002 0.998 0.000
T38.9 Other and unspecified hormone antagonists
0.002 0.998 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.002 0.998 0.000
T38.7 Androgens and anabolic congeners
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.